Biomaterial Database

[Drug treatment of tobacco dependence]. 2009

H M Friederich, and A Batra

Universitätsklinik für Psychiatrie und Psychotherapie, Tübingen. hubertus.friederich@med.uni-tuebingen.de

UI	MeSH Term	Description	Entries
D009538	Nicotine	Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.	Nicotine Bitartrate,Nicotine Tartrate
D011810	Quinoxalines		Quinoxaline
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068580	Varenicline	A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.	6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine,Champix,Chantix,Varenicline Tartrate
D001552	Benzazepines	Compounds with BENZENE fused to AZEPINES.
D014029	Tobacco Use Disorder	Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.	Nicotine Addiction,Nicotine Dependence,Nicotine Use Disorder,Tobacco Dependence,Tobacco-Use Disorder,Addiction, Nicotine,Dependence, Nicotine,Dependence, Tobacco,Disorder, Nicotine Use,Disorder, Tobacco Use,Disorder, Tobacco-Use,Nicotine Addictions,Nicotine Use Disorders,Tobacco Use Disorders
D015201	Meta-Analysis as Topic	A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.	Clinical Trial Overviews,Data Pooling,Overviews, Clinical Trial,Clinical Trial Overview,Data Poolings,Meta Analysis as Topic,Overview, Clinical Trial
D016540	Smoking Cessation	Discontinuing the habit of SMOKING.	Giving Up Smoking,Quitting Smoking,Stopping Smoking,Cessation, Smoking,Smoking Cessations,Smoking, Giving Up,Smoking, Quitting,Smoking, Stopping,Smokings, Giving Up,Up Smoking, Giving
D016642	Bupropion	A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.	(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone,Amfebutamone,Bupropion Hydrochloride,Bupropion Hydrochloride, (+-)-Isomer,Bupropion, (+-)-Isomer,Quomen,Wellbutrin,Zyban (Anti-Smoking),Zyban (Bupropion),Zyntabac
D018722	Nicotinic Agonists	Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.	Cholinergic Agonists, Nicotinic,Cholinergic Agonist, Nicotinic,Nicotinic Agonist,Agonist, Nicotinic,Agonist, Nicotinic Cholinergic,Agonists, Nicotinic,Agonists, Nicotinic Cholinergic,Nicotinic Cholinergic Agonist,Nicotinic Cholinergic Agonists